Comparison of Fractionated Versus Bolus Administration of Different Doses of Hyperbaric Bupivacaine Combined With Opioids in Spinal Anesthesia for Caesarean Section
1 other identifier
interventional
99
1 country
1
Brief Summary
This study aimed to compare the effectiveness and safety of fractionated versus bolus administration of different doses of hyperbaric bupivacaine (0.06 and 0.07 mg/cm height) combined with opioids in spinal anesthesia for cesarean section, with detailed evaluation of maternal hemodynamic effects, block characteristics and side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2025
CompletedFirst Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
November 25, 2025
CompletedNovember 25, 2025
November 1, 2025
12 months
November 14, 2025
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hemodynamic Stability (systolic, diastolic and mean arterial pressure, heart rate)
Hemodynamic parameters were recorded every 2 minutes for 10 minutes, then every 5 minutes until 30 minutes, then every 15 minutes until surgery completion.
Perioperative/Periprocedural - before spinal anesthesia and then during the cesarean section until its completion
Secondary Outcomes (1)
Spinal block characteristics (sensory block level and duration, motor block duration, analgesia duration)
Perioperative/Periprocedural
Study Arms (3)
Bolus bupivacaine (0.07 mg/cm)
ACTIVE COMPARATORFractionated bupivacaine (0.07 mg/cm)
EXPERIMENTALFractionated bupivacaine (0.06 mg/cm)
ACTIVE COMPARATORInterventions
* Group F7: received a fractionated administration of bupivacaine (0.07 mg/cm); * Group F6: received a fractionated administration of the reduced dose of bupivacaine (0.06 mg/cm).
• Group B: received a bolus administration of the total dose of 0.5% hyperbaric bupivacaine (0.07 mg/cm height)
Eligibility Criteria
You may qualify if:
- singleton full-term pregnancy scheduled for cesarean section under spinal anesthesia
- ASA physical status II-III
- age 18-50 years
- height from 140 to 180 cm
- body weight from 40 to 130 kg
You may not qualify if:
- patient refusal
- contraindications to spinal anesthesia
- allergy to amide-type local anesthetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kyiv Perinatal Center
Kyiv, Ukraine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 25, 2025
Study Start
June 30, 2024
Primary Completion
June 15, 2025
Study Completion
June 15, 2025
Last Updated
November 25, 2025
Record last verified: 2025-11